Literature DB >> 8595763

Regulation of bone formation by bone morphogenetic proteins and other growth factors.

G R Mundy1.   

Abstract

Bone formation in adult humans is a complex and closely regulated process. It usually occurs at sites of previous osteoclastic bone resorption. It also may occur in the growing long bones during endochondral bone formation, and appositional bone formation also can appear during growth and adolescence without prior local resorption, particularly on periosteal surfaces. The cellular events involved in bone formation include chemotaxis of osteoblast precursors; proliferation of committed osteoblast precursors; differentiation, including expression of growth regulatory factors and the structural proteins of bone, such as osteocalcin, osteopontin, and Type I collagen; and mineralization. It is clear that these cellular events must be under very tight regulatory control. They may all be modulated by systemic hormones, including the calciotropic hormones, parathyroid hormone and 1,25 dihydroxyvitamin D and other systemic hormones, such as the pituitary and thyroid hormones and sex steroids, but probably are modulated predominantly by local factors or cytokines generated in the bone cell microenvironment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8595763     DOI: 10.1097/00003086-199603000-00004

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  18 in total

1.  Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice.

Authors:  Yoshinori Seo; Hidefumi Fukushima; Toshimasa Maruyama; Kayoko Nakao Kuroishi; Kenji Osawa; Kenichi Nagano; Kazuhiro Aoki; Falk Weih; Takahiro Doi; Min Zhang; Keiichi Ohya; Takenobu Katagiri; Ryuji Hosokawa; Eijiro Jimi
Journal:  Mol Endocrinol       Date:  2012-01-26

2.  Accelerated osteoblast mineralization on a conductive substrate by multiple electrical stimulation.

Authors:  Shiyun Meng; Ze Zhang; Mahmoud Rouabhia
Journal:  J Bone Miner Metab       Date:  2011-02-17       Impact factor: 2.626

3.  [Ex-vivo gene therapy with BMP-4 for critically sized defects and enhancement of fracture healing in an osteoporotic animal model].

Authors:  T Rose; H Peng; A Usas; C Josten; F H Fu; J Huard
Journal:  Unfallchirurg       Date:  2005-01       Impact factor: 1.000

4.  Expression, purification, bioactivity, and partial characterization of a recombinant human bone morphogenetic protein-7 produced in human 293T cells.

Authors:  J C Bustos-Valenzuela; E Halcsik; E J Bassi; M A Demasi; J M Granjeiro; M C Sogayar
Journal:  Mol Biotechnol       Date:  2010-10       Impact factor: 2.695

Review 5.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

6.  The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization.

Authors:  Millie Hughes-Fulford; Chai-Fei Li
Journal:  J Orthop Surg Res       Date:  2011-02-09       Impact factor: 2.359

7.  Characterization of collagen II fibrils containing biglycan and their effect as a coating on osteoblast adhesion and proliferation.

Authors:  Timothy Douglas; Sascha Heinemann; Ute Hempel; Carolin Mietrach; Christiane Knieb; Susanne Bierbaum; Dieter Scharnweber; Hartmut Worch
Journal:  J Mater Sci Mater Med       Date:  2007-09-13       Impact factor: 3.896

8.  Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease.

Authors:  Jian Ruan; Timothy N Trotter; Li Nan; Rongcheng Luo; Amjad Javed; Ralph D Sanderson; Larry J Suva; Yang Yang
Journal:  Bone       Date:  2013-07-27       Impact factor: 4.398

9.  Comparison between 8-prenylnarigenin and narigenin concerning their activities on promotion of rat bone marrow stromal cells' osteogenic differentiation in vitro.

Authors:  L G Ming; B F Ge; M G Wang; K M Chen
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

10.  Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population.

Authors:  Tae-Ho Kim; Jung Min Hong; Bermseok Oh; Yoon Shin Cho; Jong-Young Lee; Hyung-Lae Kim; Jong-Eun Lee; Mi-Hyun Ha; Eui Kyun Park; Shin-Yoon Kim
Journal:  Exp Mol Med       Date:  2008-08-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.